From professional translators, enterprises, web pages and freely available translation repositories.
vantas
vantas
Last Update: 2011-10-23
Usage Frequency: 7
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
vantas ne semble pas faire exception.
there is no indication that any of the members within this class differs with respect to efficacy and safety, and vantas seems to be no exception in that respect.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
vantas est une marque déposée de paladin labs inc.
vantas is a registered trademark of paladin labs inc.
Last Update: 2015-05-14
Usage Frequency: 1
Quality:
vantas md doit être retiré après 12 mois de traitement.
what the non medicinal ingredients are).
Last Update: 2015-05-14
Usage Frequency: 1
Quality:
la dose recommandée de vantas md est de un implant pendant 12 mois.
after the cut has healed, you can go back to your normal activities.
Last Update: 2015-05-14
Usage Frequency: 1
Quality:
on ignore si vantas md peut interagir avec d’autres médicaments.
avoid heavy lifting and exercise for 7 days.
Last Update: 2015-05-14
Usage Frequency: 1
Quality:
rÉsumÉ gÉnÉral de l’ Évaluation scientifique de vantas (voir l’ annexe i)
overall summary of the scientific evaluation of vantas (see annex i)
Last Update: 2012-04-11
Usage Frequency: 3
Quality:
comment conserver ce mÉdicament conserver vantas md au réfrigérateur (entre 2 et 8 °c).
how to store it store under refrigeration (2 to 8 °c).
Last Update: 2015-05-14
Usage Frequency: 1
Quality:
l'innocuité locale de vantas a fait l'objet d'études suffisantes.aucune étude comparative supplémentaire n'est nécessaire.
the local safety of vantas is sufficiently investigated and further comparative studies are not necessary.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
summary basis of decision (sbd) vantas ® , histrelin acetate subdermal implant 50 mg, paladin labs inc., submission control no. 092567
sommaire des motifs de décision (smd), vantas md, implant sous-cutané d’acétate d’histréline, 50 mg, paladin labs inc., n o de contrôle de la présentation 092567
Last Update: 2015-05-14
Usage Frequency: 1
Quality: